Shuttle pharmaceuticals

WebApr 12, 2024 · Shuttle Pharmaceuticals had issued 1,225,888 shares in its IPO on August 31st. The total size of the offering was $9,966,469 based on an initial share price of $8.13. … WebSep 20, 2024 · Shuttle Pharmaceuticals Anatoly Dritschilo, M.D., CEO 240-403-4212 [email protected]. Investor Contacts Lytham Partners, LLC Robert Blum, Joe Dorame, Joe Diaz 602-889-9700

Shuttle Pharmaceuticals Holdings Revenue 2024-2024 SHPH

WebMar 31, 2024 · Shuttle Pharmaceuticals Holdings Profile Shuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. WebShuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. It also offers cancer treatments with surgery ... irvine park summer camp https://hssportsinsider.com

Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH)

WebMar 9, 2024 · Game Changing Potential. Shuttle Pharmaceuticals is developing first-in-class therapies that are designed to cure cancer and improve the outcomes of patients … Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company leveraging our … WebMar 22, 2024 · Shuttle Pharmaceuticals Anatoly Dritschilo, M.D., CEO 240-403-4212 [email protected] Investor Contacts Lytham Partners, LLC Robert Blum 602-889-9700 [email … WebShuttle Pharmaceuticals, Inc. is a pharmaceuticals company based out of 1 RESEARCH CT, Rockville, Maryland, United States. Industries. Pharmaceutical Manufacturing. Company … irvine pd careers

Shuttle Pharmaceuticals Announces Closing of Initial Public Offering

Category:Shuttle Pharmaceuticals Provides Fiscal Year 2024 Corporate …

Tags:Shuttle pharmaceuticals

Shuttle pharmaceuticals

SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Management

WebMar 22, 2024 · Shuttle Pharmaceuticals Anatoly Dritschilo, M.D., CEO 240-403-4212 [email protected]. Investor Contacts Lytham Partners, LLC Robert Blum 602-889 … WebThe stock price for Shuttle Pharmaceuticals ( NASDAQ: SHPH) is $ 1.3116 last updated Today at April 11, 2024 at 2:53 PM UTC. Q.

Shuttle pharmaceuticals

Did you know?

WebDec 13, 2016 · Quick Take. Shuttle Pharmaceuticals (SPHR) has filed to raise up to $36 million in its IPO. The company is developing a drug to sensitive cancer cells to radiation therapy. It is only in Phase 1 ... Web1 day ago · Shuttle announces research agreement with Georgetown University for SP-2-225 03/22/23-8:03AM EST Thefly.com Shuttle Pharmaceuticals Provides Fiscal Year 2024 Corporate Update

WebAug 30, 2024 · Aug 30, 2024, 16:40 ET. ROCKVILLE, Md., Aug. 30, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH ), a discovery and development … WebAug 16, 2024 · Shuttle Pharmaceuticals, Inc., based in Rockville, MD, is a drug discovery and development company with the founding objective to develop and commercialize radiation modifying agents for cancer treatment, including sensitizers, protectors and mitigators of radiation effects or damage.

WebSep 9, 2024 · Shares of Shuttle Pharmaceuticals Holdings ( SHPH -2.16%) climbed 160.4% this week, according to data from S&P Global Intelligence. The stock closed at $14.90 last … WebSep 2, 2024 · Newly public Shuttle Pharmaceuticals (SHPH) stock dropped 75% in late morning trading Friday after soaring 545% over the past two sessions following its $10M initial public offering...

WebSep 6, 2024 · Shuttle Pharmaceuticals Anatoly Dritschilo, M.D., CEO 240-403-4212 [email protected] Investors Lytham Partners, LLC Robert Blum, Managing Partner 602-889-9700 …

WebJun 27, 2024 · Rockville biotech Shuttle Pharmaceuticals Holdings Inc. is looking to raise up to $15 million in an initial public offering — more than five years after first signaling its intent to go public ... irvine park railroad pumpkin patchWebApr 7, 2024 · The 26.30% of Shuttle Pharmaceuticals Holdings Inc.’s shares are in the hands of company insiders while institutional holders own 3.70% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.18 million on Mar 14, 2024, giving us a short ratio of 1.72. portchester road bournemouthWebMar 31, 2024 · Shuttle Pharmaceuticals Holdings, Inc., a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer … irvine park railroad trainWebShuttle Pharmaceuticals Holdings Inc. shares were up 35%, to $20.04, after the company said its initial public offering of 1.23 million units of common stock and warrants at $8.13 … portchester railway stationWebAug 30, 2024 · About Shuttle Pharmaceuticals. Founded in 2012 by faculty members of the Georgetown University Medical Center, Shuttle Pharmaceuticals is a discovery and … irvine park railroad logo imagesWebReuters · 02/23 06:38. Shuttle Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company. It is focused on improving the outcomes of cancer patients … irvine pediatric dentistry and orthodonticsWebMar 15, 2024 · SHPH Shuttle Pharmaceuticals Holdings Inc Annual Report (10-k) FORWARD LOOKING STATEMENTS . This Annual Report on Form 10-K (including the section … portchester road bournemouth postcode